Table 4 The effect sizes of the primary and secondary outcomes of the participants with NSCLBP (N=70)
characteristic | Effect size | |
|---|---|---|
Mean difference (95% CI) | Cohen’s d (95% CI) | |
Pain as a Primary Outcome Measure | ||
NRS Score (10) | ||
6w | -0.57 (-1.62 to 0.48) | -0.23 (-0.70 to 0.24) |
10w | -1.54 ( -2.59 to -0.49) | -0.62 ( -1.10 to -0.14) |
22w | -2.20 (-3.25 to -1.15) | -0.89 (-1.38 to -0.39) |
Secondary Outcome Measures | ||
ODI Score (60) | ||
6w | -0.09 (-6.19 to 6.02) | -0.01 (-0.47 to 0.46) |
10w | -1.8 (-7.90 to 4.30) | -0.12 (-0.59 to 0.34) |
22w | -4.4 (-10.50 to 1.70) | -0.31 (-0.78 to 0.17) |
TSK Score (68) | ||
6w | 1.17 (-2.98 to 5.33) | 0.12 (-0.35 to 0.59) |
10w | -1.74 (-5.90 to 2.41) | -0.18 (-0.65 to 0.29) |
22w | -3.57 (-7.73 to 0.58) | -0.37 (-0.84 to 0.11) |
PCS Score (52) | ||
6w | -2.49 (-7.08 to 2.11) | -0.32 (-0.79 to 0.16) |
10w | -3.43 (-8.03 to 1.17) | -0.29 (-0.76 to 0.18) |
22w | -3.17 (-7.77 to 1.43) | -0.40 (-0.87 to 0.08) |
SF36 Score (400) | ||
6w | 2.12 (-7.97 to 12.21) | 0.09 (-0.38 to 0.57) |
10w | 4.24 (-5.85 to 14.33) | 0.18 (-0.29 to 0.65) |
22w | 8.47 (-1.62 to 18.56) | 0.36 (-0.12 to 0.83) |
FABQ Score (96) | ||
6w | 2.83 (-6.16 to 11.82) | 0.14 (-0.34 to 0.60) |
10w | -2.00 (-10.99 to 6.99) | -0.09 (-0.56 to 0.37) |
22w | -4.00 (-12.99 to 4.99) | -0.19 (-0.66 to 0.28) |
Flexion ROM (cm) | ||
6w | -0.40 (-7.11 to 6.31) | -0.03 (-0.49 to 0.44) |
10w | -0.86 (-7.56 to 5.85) | -0.05 (-0.52 to 0.41) |
22w | -2.46 (-9.16 to 4.25) | -0.16 (-0.62 to 0.31) |